Evaluating the Efficacy of Artificial Intelligence-based Computer Aided Diagnosis Software That Assists in Determining Whether or Not to Conduct Amyloid PET for the Diagnosis of Alzheimer's Disease by Predicting Amyloid PET Positivity in Mild Cognitive Impairment Patients
Clinical trial NCT05383053 · COMPLETED
Trial details
- NCT number
- NCT05383053
- Sponsor
- Neurozen Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-07-22
- Primary completion
- 2022-08-10
- Enrollment
- 227
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.